|
Match
|
Document |
Document Title |
|
|
US20090285803 |
ANTI-PirB ANTIBODIES
The present invention relates generally to neural development and neurological disorders. The invention specifically concerns identification of novel modulators of the myelin-associated inhibitory...
|
|
|
US20090275124 |
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
Provided are anti-idiotypic antibodies specific for a CDR of an anti-MMP-14 antibody for use as reagents in novel assays for anti-MMP-14 antibodies, pharmaceutical compositions and vaccines.
|
|
|
US20090274707 |
Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating...
|
|
|
US20090263380 |
ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZING THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII
The present invention is related to a monoclonal anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the C1 domain of Factor VIII, as well as to a cell line...
|
|
|
US20090263894 |
ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF
The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies.
|
|
|
US20090232822 |
LUNG DISEASE TARGETS AND USES THEREOF
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
|
|
|
US20090220493 |
Reagents and methods for inducing an immune response to prostate specific antigen
The invention is an apparatus and method for the treatment of prostate cancer, and involves administering an antibody that specifically binds with prostate antigen.
|
|
|
US20090215092 |
Antibodies for Anthrax
A targeted approach is described for the production of biological recognition elements capable of fast, specific detection of anthrax spores on biosensor surfaces. Single chain antibodies (scFvs)...
|
|
|
US20090148449 |
Antibodies against cd38 for treatment of multiple myeloma
Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the...
|
|
|
US20090130094 |
Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII
The invention relates to an anti-idiotypical antibody targeting an antibody inhibiting the human factor VIII, said inhibiting antibody targeting the C2 region of the human factor VIII, the variable...
|
|
|
US20090124022 |
ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF
The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies.
|
|
|
US20090098128 |
NPC1L1 orthologues
The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e.g., in screening assays, are also set forth.
|
|
|
US20090087427 |
BIOLOGICAL MATERIALS AND USES THEREOF
The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell...
|
|
|
US20090074799 |
ANTIBODIES TO CLASS II CYTOKINE RECEPTOR-7
Antibodies to novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a...
|
|
|
US20090068172 |
Compositions and methods comprising binding proteins for adalimumab
Compositions and methods comprising proteins that bind specifically to adalimumab are disclosed herein. Adalimumab is a monoclonal antibody specific for the cytokine TNF-α and was developed to...
|
|
|
US20090053294 |
Anti Mineralocorticoid Therapy of Infection
Antimineralocorticoid compounds are disclosed for use in the prophylaxis and therapy of viral infections, especially the retroviral infection by HIV. These compounds can be administered alone or in...
|
|
|
US20090010924 |
Apoptotic Anti-IgE Antibodies
The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
|
|
|
US20090004237 |
B7-Like Molecules and Uses Thereof
The present invention provides B7-Like (B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for...
|
|
|
US20080305038 |
Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells
The present invention refers to novel conjugate molecules and their use or the transport of nano- and macromolecular structures into cells and/or the nucleus. More particularly, the present...
|
|
|
US20080274102 |
Antibodies to Nik, Their Preparation and Use
An antibody or antibody fragment preparation being capable of specifically binding the amino acid sequence 60-76, 86-98, 135-149, 215-227, 363-377, 385-397, 405-419, 427-440, 509-522, 605-619,...
|
|
|
US20080267988 |
Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
Optimization and validation of a serum test confirms symptomatic autoimmune diseases e.g. multiple sclerosis (MS) or rheumatoid arthritis, and identifies early, silent diseases. The methods involve...
|
|
|
US20080268459 |
Anti-Lewis Y Anti-Idiotypic Antibodies and Uses Thereof
This invention provides anti-idiotype antibodies specific for Anti-Lewis Y monoclonal antibodies. The present invention also directed against an ELISA screening method of mAbs produced by hybridoma...
|
|
|
US20080260641 |
Human Monoclonal Antibodies Against Cd20
Isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions...
|
|
|
US20080241194 |
COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE
This invention concerns novel compositions and methods for for the protection of organs and cells from damage caused by activated lymphocytes, NK-cells and NK-like cells, more particularly...
|
|
|
US20080241138 |
SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS
Disclosed are antagonists of IL-17A and IL-17F. The antagonists are based on soluble IL-17RA and IL-17RC fusion proteins, including hybrid soluble receptors comprising portions of both IL-17RC and...
|
|
|
US20080213831 |
HUMAN CYTOKINE RECEPTOR
Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor18.”
|
|
|
US20080187528 |
ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS
The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections,...
|
|
|
US20080176268 |
MN Gene and Protein
Herein disclosed is a novel oncogene named MN or alternatively MN/CA IX. Abnormal expression of the MN gene is shown to signify oncogenesis, and diagnostic/prognostic methods for...
|
|
|
US20080161540 |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F...
|
|
|
US20080160015 |
Anti-Idiotypic Antibodies Neutralizing the Inhibitory Activity of an Inhibitory Antibody Directed Against the C1 Domain of Factor VIII
The present invention is related to a monoclonal anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the C1 domain of Factor VIII, as well as to a cell line...
|
|
|
US20080118939 |
CONJUGATE AND ITS USE AS A STANDARD IN AN IMMUNOASSAY
A composition comprising a conjugate of an anti-idiotype antibody specifically binding to a CDR region of a parent antibody and method of using polyclonal human serum immunoglobulin of class E, G,...
|
|
|
US20080044411 |
HUMAN GLP-1 MIMETIBODIES, COMPOSITIONS, METHODS AND USES
The present invention relates to at least one improved human GLP-1 mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 mimetibody or...
|